- Coordinator
- Universitaetsklinikum Hamburg-Eppendorf, Germany
- Runs
- 1 September 2026 to 31 August 2031
- Status
- Running
- EU funding
- €4.7m
- Total cost
- €4.7m
- Partners
- 12 organisations in 9 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101288379
What the project is doing
In the project's own words, from its summary on CORDIS.
The countries of Georgia, Armenia, Serbia, and Albania suffer from a public health crisis where high smoking rates drive a devastating burden of non-communicable diseases (NCDs). This crisis is compounded by a critical implementation gap: proven cessation services, standard in many HICs, are not systematically integrated into routine healthcare. The Accelerating Tobacco Cessation in Healthcare Systems (ACTS) project is an implementation science study designed to close this evidence-to-practice gap.
Using a pragmatic Hybrid Type 2 design, a large-scale, multi-country cluster randomized trial will be conducted, recruiting 1,700 patients across 34 primary and specialist care sites. The trial will simultaneously evaluate clinical effectiveness (smoking abstinence) and, importantly, a comprehensive set of implementation outcomes guided by the RE-AIM framework (e.g., reach, adoption, fidelity, cost). The Consolidated Framework for Implementation Research (CFIR) will guide the systematic, co-creative adaptation of a multi-component intervention package (behavioural support, pharmacotherapy, digital tools) to each unique national context, with a strong focus on health equity.
A foundational principle is our equitable HIC-LMIC partnership with joint scientific leadership and co-creation embedded in all activities to ensure local ownership. The primary outputs will be a validated, scalable model for integrated care, delivered through a practical ‘Implementation Playbook’ and ‘Policy Toolkit’. These tools provide policymakers with an evidence-based roadmap for sustainable, national scale-up. By generating robust, real-world implementation knowledge, ACTS will strengthen health systems, reduce the NCD burden, and provide a replicable model for other low- and middle-income countries.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitaetsklinikum Hamburg-Eppendorf | Hamburg | Germany | Coordinator |
| Institute of Public Health | Tirana | Albania | Participant |
| Universitetit Te Vlores | Vlore | Albania | Participant |
| National Institute of Health named after academician S. Avdalbekyan | Yerevan | Armenia | Participant |
| European Network for Smoking Prevention | Bruxelles / Brussel | Belgium | Participant |
| Univerzita Karlova | Praha 1 | Czechia | Participant |
| Ilia State University | Tbilisi | Georgia | Participant |
| L. Sakvarelidze National Center for Disease Control and Public Health | Tbilisi | Georgia | Participant |
| Istituto Di Ricerche Farmacologiche Mario Negri | Milano | Italy | Participant |
| Institut Ekonomskih Nauka | Beograd | Serbia | Participant |
| Institut Za Zastitu Zdravlja Srbijedr Milan Jovanovic Batut | Beograd | Serbia | Participant |
| The University of Manchester | Manchester | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI